Evidence map›Paper›PMID 24616566›Full record

ReviewWorld journal of gastroenterology2013

Role of sirtuins in ischemia-reperfusion injury.

Eirini Pantazi, Mohamed Amine Zaouali, Mohamed Bejaoui, Emma Folch-Puy, Hassen Ben Abdennebi, Joan Roselló-Catafau

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. New Potential Agent in Ovarian Ischemia Reperfusion Injury: Alpha Pinene.Journal of biochemical and molecular toxicology · 2025
    Article
  5. Article
  6. The sirtuin family in health and disease.Signal transduction and targeted therapy · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eirini PantaziEirini Pantazi, Mohamed Amine Zaouali, Mohamed Bejaoui, Emma Folch-Puy, Experimental Hepatic Ischemia-Reperfusion Unit, Institut of Biomedical Research of Barcelona-Spanish National Research Council, Barcelona, 08036 Catalonia, Spain.
Mohamed Amine ZaoualiEirini Pantazi, Mohamed Amine Zaouali, Mohamed Bejaoui, Emma Folch-Puy, Experimental Hepatic Ischemia-Reperfusion Unit, Institut of Biomedical Research of Barcelona-Spanish National Research Council, Barcelona, 08036 Catalonia, Spain.
Mohamed BejaouiEirini Pantazi, Mohamed Amine Zaouali, Mohamed Bejaoui, Emma Folch-Puy, Experimental Hepatic Ischemia-Reperfusion Unit, Institut of Biomedical Research of Barcelona-Spanish National Research Council, Barcelona, 08036 Catalonia, Spain.
Emma Folch-PuyEirini Pantazi, Mohamed Amine Zaouali, Mohamed Bejaoui, Emma Folch-Puy, Experimental Hepatic Ischemia-Reperfusion Unit, Institut of Biomedical Research of Barcelona-Spanish National Research Council, Barcelona, 08036 Catalonia, Spain.
Hassen Ben AbdennebiEirini Pantazi, Mohamed Amine Zaouali, Mohamed Bejaoui, Emma Folch-Puy, Experimental Hepatic Ischemia-Reperfusion Unit, Institut of Biomedical Research of Barcelona-Spanish National Research Council, Barcelona, 08036 Catalonia, Spain.
Joan Roselló-CatafauEirini Pantazi, Mohamed Amine Zaouali, Mohamed Bejaoui, Emma Folch-Puy, Experimental Hepatic Ischemia-Reperfusion Unit, Institut of Biomedical Research of Barcelona-Spanish National Research Council, Barcelona, 08036 Catalonia, Spain.
National Research Council · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia-reperfusion injury (IRI) remains an unresolved and complicated situation in clinical practice, especially in the case of organ transplantation. Several factors contribute to its complexity; the depletion of energy during ischemia and the induction of oxidative stress during reperfusion initiate a cascade of pathways that lead to cell death and finally to severe organ injury. Recently, the sirtuin family of nicotinamide adenine dinucleotide-dependent deacetylases has gained increasing attention from researchers, due to their involvement in the modulation of a wide variety of cellular functions. There are seven mammalian sirtuins and, among them, the nuclear/cytoplasmic sirtuin 1 (SIRT1) and the mitochondrial sirtuin 3 (SIRT3) are ubiquitously expressed in many tissue types. Sirtuins are known to play major roles in protecting against cellular stress and in controlling metabolic pathways, which are key processes during IRI. In this review, we mainly focus on SIRT1 and SIRT3 and examine their role in modulating pathways against energy depletion during ischemia and their involvement in oxidative stress, apoptosis, microcirculatory stress and inflammation during reperfusion. We present evidence of the beneficial effects of sirtuins against IRI and emphasize the importance of developing new strategies by enhancing their action.

Indexed as

AnimalsApoptosisCell SurvivalEnergy MetabolismHumansInflammationOxidative StressReperfusion InjurySignal TransductionSirtuin 1Sirtuin 3SirtuinsSirtuin 1Sirtuin 3SirtuinsApoptosisIschemia-reperfusion injuryOxidative stressSirtuin 1Sirtuin 3

Identifiers

PMID24616566
PMCPMC3837258
OpenAlexW2046700168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.